Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Morgan Stanley (MS) vs uniQure N.V. Ordinary Shares (QURE) Price & Performance

Morgan StanleyTrade
uniQure N.V. Ordinary SharesTrade

Price performance (Past 24H)

Key statistics

Morgan Stanley vs uniQure N.V. Ordinary Shares — how do they compare? Morgan Stanley trades at $182.24 (market cap $285.07B), while uniQure N.V. Ordinary Shares trades at $20.67 (market cap $1.45B). The key difference: Morgan Stanley is far larger — about 196.6× uniQure N.V. Ordinary Shares's market cap, and Morgan Stanley pays a 2.53% dividend while uniQure N.V. Ordinary Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold Morgan Stanley for 90 Days and uniQure N.V. Ordinary Shares for 0 Days on average.

MSQURE
Market Cap
$285.07B$1.45B
Volume
8,664,5333,323,243
Sector
FinancialsHealth
52-Week High
$228.42$70.59
52-Week Low
$154.37$9.03
Typical Hold Time
90 Days0 Days
Enterprise Value
$286.44B$707.46M
Dividend Yield
2.53%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Morgan Stanley

Morgan Stanley (MS) trades at $186.66, down 1.77% on the day, amid a bearish technical signal. The stock shows strong fundamentals with consistent earnings beats, revenue growth from $50.2B in 2022 to $66.0B in 2025, and a net income margin of 27.59%. Analyst consensus is bullish with a $225.50 price target, supported by growth in wealth management and AI financing.

The outlook remains positive given earnings momentum and strategic initiatives, but risks include volatile cash flows, high debt levels, and market sensitivity. Upside potential exists if the company capitalizes on capital markets recovery and AI demand, though investors should monitor leverage and macroeconomic headwinds.

uniQure N.V. Ordinary Shares

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

MS
97% Buy3% Sell
Avg holding period · 90 Days
QURE
100% Buy0% Sell
Avg holding period · 0 Days

Top news

Latest headlines on both assets

About Morgan Stanley

Morgan Stanley is a global investment bank whose history, through its legacy firms, can be traced back to 1924. The company has institutional securities, wealth management, and investment management segments. The company had about $5 trillion of client assets as well as over 70,000 employees at the end of 2021. Approximately 50% of the company's net revenue is from its institutional securities business, with the remainder coming from wealth and investment management. The company derives about 30% of its total revenue outside the Americas.

Read more on MS →

About uniQure N.V. Ordinary Shares

uniQure N.V. is a biotechnology company that develops gene therapies for rare and severe genetic diseases, marketing HEMGENIX for hemophilia B and advancing its AAV-based miQURE platform in programs such as AMT-130 for Huntington's disease.

Read more on QURE →